Navigation Links
STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
Date:1/11/2011

MONROVIA, Calif., Jan. 11, 2011 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that it expects revenue for the fourth quarter ended December 31, 2010 to exceed $14.2 million. Revenues for the full year were approximately $55 million, a 7% increase over 2009 revenues, driven by an increase of approximately 10% in revenues from the core ICL and IOL product lines.  The Company expects to announce its fourth quarter and full year 2010 results on March 1, 2011.

"Our estimated fourth quarter revenues were driven by strong growth in the Visian ICL product lines, which achieved a record in both revenues and units," said Barry G. Caldwell, president and CEO of STAAR Surgical.  "Expected ICL revenues were up approximately 13% from the prior year's fourth quarter and 8% from the previous third quarter 2010 record.  Unit volume grew approximately 20% from the fourth quarter last year.  During the quarter, approximately 10% of our ICL sales in our recently introduced expanded range Visian ICL models were in segments where we have not previously participated, specifically low myopes and toric hyperopes.  This demonstrates the demand and opportunity for the expanded treatment range, which received CE Mark approval during late third quarter.  The strong growth for the Visian ICL continued in China, India and the Middle East during the quarter, and revenues in Japan began to reflect our extremely positive efforts in that market."

STAAR also announced that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its KS-X2 Preloaded Single Piece Hydrophobic Acrylic Injector System in Japan.  STAAR has been offering the three-piece KS-X system in Japan for two years and in selective CE Mark countries f
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
2. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
3. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
4. STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter
5. STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
6. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
7. MiMedx Completes Acquisition of Surgical Biologics
8. Zimmer Announces Acquisition of SoPlus Orthopaedic Surgical Power Tools Company
9. MiMedx Announces Agreement to Acquire Surgical Biologics
10. $30 Million CABG Market Supported by Use of Intuitive Surgicals da Vinci Robot in Minimally Invasive CABG Procedures
11. Reportlinker Adds Global Surgical Incision Closures Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... -- Kinex Pharmaceuticals announced today that the first patient ... Institute. KX2-361 (KX02), a dual src/pre-tubulin inhibitor, ... inhibitory activity against a broad panel of brain tumor ... (T98G), the most widely used chemotherapy for the treatment ... model, KX2-361 consistently clears brain tumors after 4 weeks ...
(Date:12/24/2014)... and FARMINGTON, Conn. , Dec. ... MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific ... significant unmet medical need and commercial potential, today ... placement of 2,050,000 shares of its common stock ... of its common stock.  Funds under the management ...
(Date:12/24/2014)... -- ResMed (NYSE: RMD ) today announced its ... device manufacturer BMC Medical Co., Ltd. The ... below infringe ResMed,s patents, and entered an order prohibiting BMC ... the United States : , iVolve nasal ... nasal pillows mask , iVolve full face mask ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... , STUART, Fla., ... is pleased to announce the addition of Mr. Joseph Farish and ... is s graduate of the University of Florida (Bachelor of Arts ... been a member of the Florida Bar for more than 59 ...
... LONDON and PHILADELPHIA, Dec. 11 In a ... experienced a median survival of 14 months when treated with ... results of the Phase III study in HER2-positive metastatic breast ... Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 ...
Cached Medicine Technology:Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 2Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 3Liberator Medical Strengthens its Board of Directors with the Addition of Mr. Joseph Farish and Mr. Robert S. Cuillo 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 2GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 3GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 4GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 5GSK Study Showed Targeted Therapy Combination Achieved 14 Month Overall Survival in Patients with Advanced Breast Cancer 6
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive high-tech ... marketing of a series of induction heating equipment. Today, ... of induction brazing equipments . , According to ... refers to the joining of two or more ... manager says that there are fundamental differences in the ...
(Date:12/25/2014)... 26, 2014 This is a professional ... global Sterilizers industry with a focus on the Chinese ... status of the Sterilizers manufacturers and is a valuable ... interested in the industry. This report provides a basic ... manufacturing technology. In this part, the report presents the ...
(Date:12/25/2014)... The report “TS-1 (Colorectal Cancer) – Forecast and ... landscape, unmet needs, current pipeline and commercial opportunities in ... which is typically used for treating colorectal cancer. It ... gastric cancer and pancreatic cancer. TS-1 is composed of ... approved in 1999 in Japan for the treatment of ...
(Date:12/25/2014)... December 26, 2014 Recently, iFitDress.com, the popular ... women, has announced its new selection of black one-shoulder ... on sale now; they are available at discounted prices, up ... “The promotion will last for three weeks only. You know, ... Those who are interested in our new items can visit ...
(Date:12/25/2014)... Recently, BellasDress has launched its Christmas ... BellasDress has chosen their best-selling lace wedding dresses, vintage ... holiday season. , Now, BellasDress.com features popular women’s ... at discount prices. The business hopes everyone can have ... , “All our elegant products are made with ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... treatment failure in more than 90 percent of metastatic ... rates. Dean Ho, an associate professor of ... a tiny carbon particle called a nanodiamond may offer ... In studies of liver and breast cancer models in ...
... Institute of Technology have found support for the theory that ... it stores readily available items. Memory researchers have long debated ... capacity and function of each layer is. In a ... Cognitive Psychology, researchers found that short-term memory is made ...
... Ortega, MD, an anesthesiologist at Boston Medical Center (BMC) ... of Medicine (BUSM), received a Letter of Commendation from ... video on pulse oximetry. The video, which has been ... a major component of the WHO,s efforts to improve ...
... Maureen Salamon HealthDay Reporter , WEDNESDAY, March ... and family life, fueled by constant availability via cell ... women, a new study finds. Researchers from the ... American workers to determine gender differences in how men ...
... with taking aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) ... of elevations in a particular inflammatory factor in the ... of Gastroenterology , investigators from Massachusetts General Hospital ... baseline levels of a novel inflammatory marker indicated increased ...
... 100 million Americans may currently be misclassified as having ... the Veterans Affairs Health Care System in Minneapolis and ... show that these people are not actually more likely ... i.e. below 120/80. Taylor and colleagues, article in the ...
Cached Medicine News:Health News:Tiny gems take big step toward battling cancer 2Health News:New study proves the brain has 3 layers of working memory 2Health News:BMC doctor recognized by World Health Organization for pulse oximetry training video 2Health News:Women Feel More Guilt, Distress About Work Intrusions at Home, Study Says 2Health News:Women Feel More Guilt, Distress About Work Intrusions at Home, Study Says 3Health News:Aspirin's ability to protect against colorectal cancer may depend on inflammatory pathways 2Health News:Redefining normal blood pressure 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: